Amylyx Pharmaceuticals, Inc. — Investor Relations & Filings
Amylyx Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery and development of novel therapies for neurodegenerative diseases and other conditions with high unmet medical needs. The company's primary therapeutic candidate was AMX0035 for the treatment of amyotrophic lateral sclerosis (ALS). In April 2024, following the results of a Phase 3 clinical trial, Amylyx announced it would voluntarily withdraw the marketing authorizations for AMX0035 in the U.S. and Canada. The company is advancing a pipeline of other investigational therapies, utilizing a modality-agnostic approach to match treatments to diseases based on mechanistic rationale and rigorous scientific data.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM 4/A SUBMISSION | 2023-03-24 | English | |
| FORM 4 SUBMISSION | 2023-03-23 | English | |
| 8-K | 2023-03-21 | English | |
| FORM 4 SUBMISSION | 2023-03-21 | English | |
| FORM 4 SUBMISSION | 2023-03-21 | English | |
| FORM 4 SUBMISSION | 2023-03-21 | English |
Browse filings by year
12 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2023
15 filings
| |||||
| 12920409 | FORM 4/A SUBMISSION | 2023-03-24 | English | ||
| 12920410 | FORM 4 SUBMISSION | 2023-03-23 | English | ||
| 12920412 | 8-K | 2023-03-21 | English | ||
| 12920415 | FORM 4 SUBMISSION | 2023-03-21 | English | ||
| 12920413 | FORM 4 SUBMISSION | 2023-03-21 | English | ||
| 12920414 | FORM 4 SUBMISSION | 2023-03-21 | English | ||
| 12920418 | FORM 4 SUBMISSION | 2023-03-21 | English | ||
| 12920416 | FORM 4 SUBMISSION | 2023-03-21 | English | ||
| 12920420 | FORM 4 SUBMISSION | 2023-03-21 | English | ||
| 12920417 | FORM 4 SUBMISSION | 2023-03-21 | English | ||
| 12920419 | FORM 4 SUBMISSION | 2023-03-21 | English | ||
| 12920426 | FORM 3 SUBMISSION | 2023-03-21 | English | ||
| 12920425 | FORM 4 SUBMISSION | 2023-03-17 | English | ||
| 12920424 | Regulatory Filings 2023 | 2023-03-16 | English | ||
| 12920421 | Regulatory Filings 2023 | 2023-03-16 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Amylyx Pharmaceuticals, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31865/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31865 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31865 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31865 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31865}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Amylyx Pharmaceuticals, Inc. (id: 31865)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.